![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
A study presented at SNM's 57th Annual Meeting suggests that medication ingested to control blood-sugar levels can skew the results of cancer screenings using positron emission tomography (PET), a molecular imaging technique, by increasing absorption in the gut of the PET imaging agent called fluorodeoxyglucose (18F-FDG), which mimics sugar inside the body. "The use of certain medications can ...
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Healthbeat: Lowering your risk for prostate cancer | cancerfr | Skin Cancer | 0 | 09-02-2010 10:56 PM |
| MabCure, Inc. Announces Positive Results For New Ovarian Cancer Diagnostic Blood Test | cancerfr | Ovarian Cancer | 0 | 07-28-2010 03:16 PM |
| JANUMET results in greater blood sugar reductions in patients with type 2 diabetes co | cancerfr | Multiple Myeloma/Other Plasma Cell Neoplasms | 0 | 07-19-2010 06:41 PM |